Search Results 1-10 of 16622 for non-drug GLP-1 modulation

  1. Effects Of Long-Acting GLP-1 (Glucagon-like Peptide-1) Or Dual Incretin (GLP-1 And GIP [Glucose-dependent Insulinotropic Peptide]) Modulation On Gastric Motor Functions - Mayo Clinic

    By condition, treatment or drug name. Search tips. Effects Of Long-Acting GLP-1 (Glucagon-like Peptide-1) Or Dual Incretin (GLP ... * Not currently on ...

  2. New study links combination of hormone therapy and tirzepatide to greater weight loss after menopause - Mayo Clinic News Network

    ... GLP-1-based obesity medication semaglutide. No previous studies have examined whether hormone therapy might influence outcomes with tirzepatide. Dr ...

  3. Effects of Hyperglycemia on Myocardial Perfusion in Humans With and Without Type 2 Diabetes - Mayo Clinic

    About this study. The overall goal of this proposal is to determine the effects of acute hyperglycemia and its modulation by Glucagon-like Peptide-1 (GLP-1) ...

  4. Evaluation of the changes in glycemic and physiologic parameters (sleep, cardioadapatbility parameters) in non-diabetic patients being treated for obesity with GLP1 Agonist and GLP-1/ GIP agonist medications. - Mayo Clinic

    By condition, treatment or drug name. Search tips ... non-diabetic patients being treated for obesity with GLP1 Agonist and GLP-1/ GIP agonist medications.

  5. Adrian Vella, M.D. - Mayo Clinic Faculty Profiles

    Vella's research team has recently shown that GLP-1 also is produced in the islet and modulates islet function to improve blood glucose homeostasis. Effects of ...

  6. Contribution of GLP-1 Receptor - Mayo Clinic

    By condition, treatment or drug name. Search tips ... The GLP-1 receptor gene is found on the beta cells of the pancreas. ... Additional contact information. Non- ...

  7. GLP-1RA and thyroid cancer: New study suggests detection bias, not causation - Mayo Clinic

    GLP-1RA and thyroid cancer: New study suggests detection bias, not causation. Aug. 21, 2025. Glucagon-like peptide 1 receptor agonists (GLP-1RAs) are ...

  8. Examining the impact of GLP-1 receptor agonist use on quality of bowel preparation for colonoscopy - Mayo Clinic

    The rapidly rising use of glucagon-like peptide-1 (GLP-1) ... No significant difference in bowel preparation ... © 1998-2025 Mayo Foundation for Medical Education ...

  9. Diabetes treatment: Medications for type 2 diabetes - Mayo Clinic

    ... medicine called a dual-acting GLP-1/GIP agonist. Action. Cause the release of ... No one diabetes treatment is best for everyone. What works for one person may ...

  10. Liraglutide (subcutaneous route) - Side effects & dosage - Mayo Clinic

    This medicine is a glucagon-like peptide-1 (GLP-1) receptor agonist. ... For non-prescription ... Do not keep outdated medicine or medicine no longer needed.